007HO12669 ZIPIT-P

Print/PDF
Registration Name OCD ERASER ZIPIT-P-ET
Registration Number HO840003125170883
Primary NAAB Code 007HO12669
Secondary Code(s) 507HO12669
Status Inactive
Controller Name Select Sires (7)
Date of Birth 1/14/2015
aAa -
DMS -
GFI 10.3%
Genetic Codes * TR PC TV TL TY TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T, HHP-C
Sire KERNDTWAY ERASER P-ET
MGS MOUNTFIELD SSI DCY MOGUL-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin AB
INDEXES
NM$ -77, 91% R CM$ -87
NM Percentile 15% FM$ -54
GTPI 2501 GM$ -20
PRODUCTION TRAITS
704 Dtrs 259 herds 83 % US 98% R
Milk 456 Fat, % -13 , -0.12%
SCS 2.92, 98% R Protein, % 6 , -0.03%
Feed Saved 92 , 63% R Milking Speed 7 , 87% R
Health & Fertility
Productive Life -0.6      97% R Mastitis -0.5      93% R
Heifer Livability -1.4       82% R Metritis -0.1      88% R
Livability -3.8      91% R D. Abom -0.1      92% R
DPR 0.9      98% R Ketosis -0.3      88% R
FSC 5.0      98% R R. Placenta -0.1      89% R
HCR 0.4      94% R Milk Fever 0.1      80% R
CCR 1.8      98% R
SCR -        -
DIA -1.3      59% R
RSP -2.0      75% R
Calving Traits
Sire CE 1.7      96% R 938 Obs
Daughter CE 2.2      94% R 389 Obs, 220 Dtrs
Sire SB 3.9      93% R 919 Obs
Daughter SB 4.6      92% R 376 Obs, Dtrs
Gestation Length 1.2      99% R 205 Obs, 1009 Dtrs
Early First Calving -2.8      95% R 183 Obs, 510 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
231 Dtrs 112 herds 97% R
PTA Type 0.77 UDC 0.53
HCC 0.84 BWC -0.68
FLC -0.19
Linear Traits
Stature 1.30
Tall
Strength -0.68
Strong
Body Depth 0.13
Deep
Dairy Form 1.30
Open
Rump Angle 1.80
Sloped
Thurl Width 0.64
Sloped
Rear Legs-Side View 0.64
Wide
Rear Legs-Rear View -0.30
H.-in
Foot Angle 0.24
Steep
Feet & Legs Score 0.32
High
F.U. Attachment 2.17
Curved
Rear Udder Height 2.12
High
Rear Udder Width 0.97
Wide
Udder Cleft 0.07
Strong
Udder Depth -0.30
H.-in
Front Teat Placement -0.94
Wide
Rear Teat Placement -0.74
Wide
Teat Length 2.01
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO